INOTEK PHARMACEUTICALS CORPORATION

Company

ROCKET PHARMACEUTICALS, INC.

Filed

October 5, 2017

Accession Number

0000902664-17-003915

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →